ABSTRACT: The photoactivatable sterol probe [3R-3 H]6-Azi-5R-cholestan-3 -ol ([ 3 H]Azicholesterol) was used to identify domains in the Torpedo californica nicotinic acetylcholine receptor (nAChR) that interact with cholesterol. [ 3 H]Azicholesterol partitioned into nAChR-enriched membranes very efficiently (>98%), photoincorporated into nAChR subunits on an equal molar basis, and neither the pattern nor the extent of labeling was affected by the presence of the agonist carbamylcholine, consistent with photoincorporation at the nAChR lipid-protein interface. Sites of [ 3 H]Azicholesterol incorporation in each nAChR subunit were initially mapped by Staphylococcus aureus V8 protease digestion to two relatively large homologous fragments that contain either the transmembrane segments M1-M2-M3 (e.g., RV8-20) or M4 (e.g., RV8-10). The distribution of [ 3 H]Azicholesterol labeling between these two fragments (e.g., RV8-20, 29%; RV8-10, 71%), suggests that the M4 segment has the greatest interaction with membrane cholesterol. Photolabeled amino acid residues in each M4 segment were identified by Edman degradation of isolated tryptic fragments and generally correspond to acidic residues located at either end of each transmembrane helix (e.g., RAsp-407). [ 3 H]Azicholesterol labeling was also mapped to peptides that contain either the M3 or M1 segment of each nAChR subunit. These results establish that cholesterol likely interacts with the M4, M3, and M1 segments of each subunit, and therefore, the cholesterol binding domain fully overlaps the lipid-protein interface of the nAChR.
The Torpedo nicotinic acetylcholine receptor (nAChR) 1 is the most extensively studied member of a superfamily of ligand-gated ion channels that includes muscle and neuronal nAChRs, serotonin 5-HT 3 receptors, gamma-amino butyric acid type A receptors (GABA A ), and glycine receptors (1, 2) . Each Torpedo nAChR is a pentamer comprised of four homologous transmembrane subunits with a stoichiometry of 2R/ /γ/δ that are arranged pseudosymmetrically around a central cation-selective ion channel. Conformational transitions, from the closed (nonconducting), to agonist-induced open (ion conducting), to desensitized (nonconducting) states, are critical for functioning of the nAChR (2) . The ability of the nAChR to undergo these transitions is profoundly influenced by the lipid composition of the bilayer (3, 4) . The presence of both anionic lipid (e.g., phosphatidylserine) and neutral lipid (e.g., cholesterol) are required for the receptor to undergo agonist-induced state transitions (3, 5) . A requirement for cholesterol is consistent with its rich abundance in Torpedo nAChR-enriched membranes (∼35% on a molar basis; 6) and its preferential interaction with the nAChR (7, 8) . The molecular interactions which underlie the effects of cholesterol on nAChR functionality are not understood. Cholesterol has no detectable effect on the overall secondary structure of the receptor as revealed by FTIR spectroscopy (9) . Yet nAChR state transitions are preserved in the presence of a single shell of lipids (∼45 lipids) surrounding the receptor protein (10) , and amino acid substitutions at residues that contact lipid have significant effects on channel gating (11, 12) . These results suggest that direct interactions between cholesterol and the nAChR lipid-protein interface exert subtle, yet critical, structural alterations that are necessary for receptor functionality.
The structure of the nAChR lipid-protein interface has been reasonably well-defined through studies employing small lipophilic photoreactive probes (12, 13) and by the cryo-electron microscopy-derived structure of the nAChR (4 Å structure; 14, 15) . Each nAChR subunit is comprised of a bundle of four transmembrane helices (M1-M4). The five M2 helices are arranged about a central axis orthogonal to the membrane forming the channel lumen. Each M2 helix is shielded from the lipid bilayer by the group of helices M1, M3, and M4. The M4 helix is located on the outside of the four helical bundle, exposing a rather broad helical face to lipid, while the M1 and M3 helices have more limited surfaces that are in contact with lipid (see Figure 4, in ref 14) .
Previous labeling studies using photoactivatable cholesterol analogues have either restricted the characterization of labeling to the intact subunit level (16, 17) and/or employed photoactivatable sterols that are not likely functional cholesterol substitutes (18, 19) . [3R- 3 H]6-Azi-5R-cholestan-3 -ol ([ 3 H]Azicholesterol) is a functional cholesterol substitute (20) in which a photoactivatable diazirine functionality has been introduced into the six position ( Figure 1 ). Irradiation of other aliphatic diazirines with long-wavelength ultraviolet light (365 nm), that is unlikely to directly activate amino acid side chains, produces reactive intermediates which react efficiently with acidic amino acids and tyrosine, as well as with glutamine, cysteine, serine, and histidine, forming adducts stable under conditons of Edman degradation (21, 22) .
In the present work, [ 3 H]Azicholesterol has been used as a photoaffinity probe to localize the regions of the nAChR that interact with membrane cholesterol. [ 3 H]Azicholesterol partitions into nAChR-enriched membranes with high efficiency (>98%) and photolabels each nAChR subunit on an equal molar basis. Neither the pattern nor the extent of labeling is affected by the inclusion of the agonist carbamylcholine, consistent with incorporation at the lipid-protein interface. Nearly three-quarters of the total [ 3 H]Azicholesterol incorporation into each nAChR subunit is localized to Staphylococcus aureus protease fragments that contain the M4 segment (e.g., RV8-10), suggesting that the transmembrane M4 helix has the greatest interaction with membrane cholesterol. In addition, [ 3 H]Azicholesterol labeling was mapped to peptides that contain either the M1 or M3 segments of each receptor subunit, which suggests that the cholesterol binding domain (M1, M3, and M4 segments) fully overlaps the lipid-protein interface of the nAChR.
EXPERIMENTAL PROCEDURES
Materials. nAChR-enriched membranes were isolated from frozen Torpedo californica electric organs obtained from Aquatic Research Consultants (San Pedro, CA) by differential and sucrose density gradient centrifugation, as described previously (23) . The final membrane suspensions in ∼38% sucrose were stored at -80°C. [ 3 H]Azicholesterol ([3R-3 H]6-Azi-5R-cholestan-3 -ol; 20 Ci/mmol)) was obtained from American Radiolabeled Chemicals (St. Louis, MO) and was stored in ethanol at -20°C. Carbamylcholine chloride was purchased from Sigma-Aldrich (St. Louis, MO), S. aureus glutamyl endopeptidase (V8 protease) from MP Biochemicals (Irvine, CA), Trypsin (TPCK-treated) from Worthington (Lakewood, NJ), Trifluoroacetic acid (TFA) from Pierce (Rockford, IL), and Genapol C-100 from Calbiochem (San Diego, CA). Prestained low-range molecular weight standards were purchased from Life Technologies, Inc. (Gaithersburg, MD).
Photolabeling of nAChR-Enriched Membranes with [ 3 H]-Azicholesterol.
Freshly thawed nAChR-enriched Torpedo membranes (in ∼38% sucrose) were diluted 4-fold with vesicle dialysis buffer (VDB, 100 mM NaCl, 0.1 mM EDTA, 0.02% NaN 3 , and 10 mM MOPS, pH 7.5) and pelleted by centrifugation (18 000 rpm for 1 h using a JA-20 rotor in a Beckman J2-HS centrifuge). Pelleted membranes were then resuspended in VDB to achieve a protein concentration of 1.25 mg/mL (∼1 µM nAChR). For photolabeling experiments, membrane aliquots in glass test tubes or vials (1 mg analytical scale; 25 mg preparative scale) were incubated with [ 3 H]Azicholesterol (from an ethanolic stock solution; final concentrations are 1.25 µM and <1% ethanol) either in the presence or absence of 400 µM carbamylcholine (carb). After 2 h in the dark at room temperature, samples were irradiated at 365 nm (Spectroline EN-280L) for 10 min at a distance of <1 cm. Photolyzed membrane suspensions were then pelleted, solubilized in electrophoresis sample buffer, and subjected to SDS-PAGE.
SDS-Polyacrylamide Gel Electrophoresis. SDS-PAGE was performed according to the method of Laemmli (24) with analytical (1.0 mm thick) and preparative (1.5 mm) separating gels comprised of 8% polyacrylamide/0.33% bisacrylamide. Following electrophoresis, nAChR subunits were visualized by staining with Coomassie Blue R-250 (0.25% (w/v) in 45% methanol, 10% acetic acid, and 45% dH 2 O) and destaining (25% methanol, 10% acetic acid, and 65% dH 2 O). For fluorography, stained gels were impregnated with fluor (Amplify; GE Biosciences) for 30 min, dried, and exposed at -80°C to Eastman Kodak X-Omat LS film for various times (3-6 weeks). 3 H incorporation into individual polypeptides was also quantified by liquid scintillation counting of excised gel slices (25) . For either analytical or preparative [ 3 H]Azicholesterol photolabeling experiments, individual nAChR subunits were fragmented by limited "in gel" digestion with S. aureus V8 protease (26, 27) . Following electrophoresis, stained 8% acrylamide gels were soaked in distilled water overnight, and nAChR subunit bands (R, , γ, δ) from each labeling condition (-/+ carb) were excised and transferred directly to the well(s) of either a 1.0 mm (analytical) or 1.5 mm (preparative) thick mapping gel, composed of a 5-cm-long 4.5% acrylamide stacking gel and a 11-cm-long 15% acrylamide separating gel. For analytical labelings, each gel slice was overlaid with 6 µg of S. aureus V8 protease in overlay buffer (5% sucrose, 125 mM TrisHCl, and 0.1% SDS, pH 6.8) and electrophoresed at 60 V constant voltage for ∼3 h and then at ∼6 mA constant current overnight. After Coomassie Blue R-250 staining (2 h) and destaining (3-4 h), analytical gels were impregnated with fluor, dried, and exposed to film (up to 16 weeks). Preparative 8% acrylamide gels (1.5 mm thick) were soaked in distilled water overnight, and each nAChR subunit was excised as a strip (∼15 cm). The gel strips were transferred to individual 15% acrylamide mapping gels and overlaid with 200 µg of V8 protease in overlay buffer. Following electrophoresis, staining, and soaking in distilled water overnight, the following subunit proteolytic fragment bands were excised, using the nomenclature of ref 12: RV8-20 (RSer-173-Glu-338), RV8-10 (RAsn-339-Gly-437), V8-22 ( Ile-173-Glu383), V8-12 ( Met-384-Ala-469), γV8-24 (γ Ala-167-Glu-372), γV8-14 (γLeu-373-Pro-489), δV8-20 (δIle192-Glu372), and δV8-11 (δLys436-Ala501). The excised proteolytic fragments were then isolated by passive diffusion into 25 mL of Elution Buffer (0.1 M NH 4 HCO 3 , 0.1% (w/v) SDS, and 1% -mercaptoethanol, pH 7.8) for 4 days at room temperature with gentle mixing (12, 18) . The gel suspensions were then filtered (Whatman No. 1 paper) and concentrated using Centriprep-10 concentrators (10 kDa cutoff, Amicon). Excess SDS was removed by acetone precipitation (>85% acetone at -20°C overnight). Proteolytic Digestions. For digestion with trypsin, acetoneprecipitated V8 protease subunit fragments, RV8-20, RV8-10, V8-22, V8-12, γV8-24, γV8-14, δV8-20, and δV8-11, were initially resuspended in a small volume (60 µL) of SDS-containing buffer (0.1 M NH 4 HCO 3 and 0.1% SDS, pH 7.8). The SDS concentration was then reduced by diluting with buffer without SDS, and Genapol C-100 was added, resulting in final concentrations of 0.02% (w/v) SDS and 0.5% Genapol C-100, pH 7.8 (1-2 mg/mL of protein). To ensure complete proteolysis, trypsin was added at a 200% (w/w) enzyme-to-substrate ratio, and the digestion was allowed to proceed for 4 days at room temperature. Small aliquots (∼5%) of the total digest were resolved on analytical (1.0 mm thick) small pore (16.5% T/6% C) Tricine SDS-PAGE gels (12, 28) . Analytical Tricine gels were placed in destain for 1 h, impregnated with fluor, dried, and exposed to film (2-12 weeks). The bulk of the tryptic digests were separated by reverse-phase HPLC. For exhaustive V8 protease digestion, acetone-precipitated V8 protease subunit fragments, RV8-20, V8-22, γV8-24, and δV8-20, were resuspended in 300 µL of 0.1 M NH 4 HCO 3 and 0.01% (w/ v) SDS, pH 7.8, then incubated with V8 protease (400% w/w) for 6 days at room temperature. Aliquots (∼10%) of each digest were resolved on an analytical Tricine SDS-PAGE gel and processed for fluorography (12-16 week exposure). The bulk of the material from each V8 protease digest was separated on individual preparative scale (1.5 mm thick) Tricine SDS-PAGE gels. Following staining and destaining of each preparative Tricine gel, select fragments were excised based upon the results of fluorographs of analytical Tricine gels as well as previous results (12) and with the aid of low-range molecular weight standards (Life Technologies, Inc.). The selected fragments, RV8-8.5K, V8-7K, γV8-7.5K, and δV8-7.5K, were then isolated by passive elution into 4 mL of elution buffer over 4 days at room temperature. The gel suspensions were filtered, concentrated (Centriprep-3, Amicon), and further purified by reversed-phase HPLC.
HPLC Purification. Protelytic fragments of nAChR subunits were purified by reversed-phase HPLC on a Shimadzu LC-10A binary HPLC system, using a Brownlee Aquapore C 4 column (100 mm × 2.1 mm). Solvent A was 0.08% trifluoroacetic acid (TFA) in water, and Solvent B was 0.05% TFA in 60% acetonitrile/40% 2-propanol. A nonlinear elution gradient at 0.2 mL/min was employed (25%-100% Solvent B in 100 min), and fractions were collected every 2.5 min (42 fractions/run). The elution of peptides was monitored by the absorbance at 210 nm, and 25 or 50 µL aliquots of each collected fraction were counted for radioactivity using liquid scintillation counting.
Sequence Analysis. Amino terminal sequence analysis was performed on a Beckman Instruments (Porton) 20/20 automated protein sequencer using gas-phase cycles (Texas Tech Biotechnology Core Facility). Pooled HPLC fractions were dried by vacuum centrifugation, resuspended in a small volume (20 µL) of 0.1% SDS, and immobilized on chemically modified glass fiber disks (Beckman Instruments), which were used to improve the sequencing yields of hydrophobic peptides. Peptides were subjected to at least 10 sequencing cycles. Alternatively, fractions containing the R-M4, -M4, γ-M4, and δ-M4 peptides, isolated by HPLC from tryptic digests of RV8-10, V8-12, γV8-14 ,and δV8-11, were sequenced on an Applied Biosystems Procise 492 protein sequencer using liquid-phase cycles. The volume of pooled HPLC fractions was reduced by vacuum centrifugation (to ∼1 mL), diluted with 2 vol of 0.1% TFA in distilled water (to reduce organic concentration), and loaded onto PVDF disks using Prosorb sample preparation cartridges (Applied Biosystems no. 401959). Approximately one-sixth of the released PTH-amino acids were analyzed for released PTH-amino acids, and the remaining five-sixths were collected for scintilation counting. During the sequence analysis of nAChR subunit fragments photolabeled by [ 3 H]Azicholesterol, we found that the very hydrophobic photolabeled cleavage products were apparently inefficiently transferred from the cleavage cartridge and/or conversion flask by the solvents normally used for sequencing. For example, when the conversion flask was rinsed with 20% CH 3 CN and then methanol prior to beginning a new sequence run, depending upon the amount of 3 H loaded in the previous sequence run, between 100 and 300 cpm were recovered from the flask (i.e., 6-20 times the normal background). Such residual radioactivity in the conversion flask was not seen in previous studies even with other hydrophobic probes such as [ 125 I]-TID (12) or [ 3 H]promegestone (19) . After sequencing samples labeled with [ 3 H]Azicholesterol, several days of washing with methanol were required to reduce the residual 3 H wash-through from ∼200 cpm/cycle to background levels (∼15 cpm). Because this inefficient transfer of labeled PTH amino acids is also likely to result in significant recovery of 3 H in the cycles following cleavage at a labeled amino acid, as detailed in Results, we interpret 3 H release profiles cautiously. Yield of PTH-derivatives was calculated from peak height compared with standards using the model 610A Data Analysis Program, version 2.1A. Initial and repetitive yields were calculated by a nonlinear least-squares regression to the equation M ) I 0 R n , where M is the observed release, I 0 is the initial yield, R is the repetitive yield, and n is the cycle number.
RESULTS

Photoincorporation of [ 3 H]Azicholesterol into nAChR-rich
Membranes. Initial photolabeling experiments were designed to characterize the general pattern of [ 3 H]Azicholesterol photoincorporation into Torpedo nAChR-enriched membranes as well as to assess the sensitivity of photoincorporation to the presence of agonist. nAChR-enriched membranes (1.25 mg/mL) were equilibrated with 1.25 µM (12, 27) . Limited V8 protease digestion of nAChR subunits reproducibly generates a set of nonoverlapping fragments (12, 23) . Inspection of a fluorograph (Figure 3 . Fragments RV8-20, V8-22, γV8-24, and δV8-20 contain the transmembrane segments M1, M2, and M3 of each subunit, and fragments RV8-10, V8-12, γV8-14, and δV8-11 contain the transmembrane segment M4 of each subunit. On the basis of liquid scintillation counting of excised gel pieces, ∼75% of the total subunit labeling resides within V8 proteolytic fragments that contain the M4 transmembrane segment (e.g., RV8-10), while ∼25% of the labeling resides within V8 proteolytic fragments [On the basis of scintillation counting of aliquots of isolated V8 protease fragments from five preparative scale labeling experiments, the relative incorporation into each fragment was (absence of agonist) RV8-20 (29%), RV8-10 (71%); V8-22 (14%), V8-12 (86%); γV8-24 (26%), γV8-14 (74%); δV8-20 (15%), δV8-11 (85%) and (presence of agonist) RV8-20 (30%), RV8-10 (70%); V8-22 (11%), V8-12 (89%); γV8-24 (28%), γV8-14 (72%);
δV8-20 (20%), δV8-11 (80%).] Mapping the Sites of [ 3 H]Azicholesterol Incorporation in M4 Segments of Each nAChR Subunit.
The M4 segments were isolated from exhaustive tryptic digests of relatively large V8 protease fragments of each nAChR subunit (RV8-10, V8-12, γV8-14, and δV8-11). When an aliquot of each tryptic digestion was resolved by Tricine SDS-PAGE, the corresponding fluorograph revealed in each case a principal band migrating with an apparent molecular weight of ∼5 kDa (Figure 4) . When the bulk of each digest was resolved by reversed-phase HPLC (Figure 5 ), for the R, , and γ subunit digests, >90% of 3 H eluted as a hydrophobic peak at the end of the gradient, while for the δ subunit, the 3 H was distributed in two hydrophobic peaks.
For the RV8-10 tryptic digest, HPLC fractions 38-41 ( Figure 5A ) were pooled and subjected to N-terminal sequence analysis. As shown in Figure 6A , sequence analysis revealed the presence of fragments beginning at RTyr-401 (274 pmol) and RSer-388 (148 pmol), overlapping sequences, each of which contains the RM4 segment beginning at RIle-409. The 3 H release pattern was rather complex, with the largest release occurring in cycles 11 (1830 cpm),12 (1460 cpm), and 20 (1460 cpm) 2 . The presence of two abundant peptides precluded a definitive assignment of 3 H release in a particular cycle with [ 3 H]Azicholesterol incorporation into a single amino acid. However, the release in cycles 11, 12, and 20 would correspond to labeling of RGlu-398, RTrp-399, and RAsp-407 in the fragment beginning at RSer-388 and/or of RLeu-411, RCys-412, and RIle-420 in the fragment beginning at RTyr-401. Since other aliphatic diazirines have been shown to efficiently photolabel acidic side chains in the nAChR agonist binding site and ion channel (21, 22) , and we have not seen efficient photolabeling of aliphatic side chains, we consider it most likely that the 3 results at least in part from labeling of RCys-412, as well as from the lag from the release in cycle 11.
For the tryptic digestion of V8-12, HPLC fractions 37-40 ( Figure 5B ) were pooled and sequenced ( Figure 6B ). The primary sequence began at Asp-427 (89 pmol), 12 amino acids before the N-terminus of M4 ( Leu-438), with secondary sequences beginning at Leu-438 (9 pmol) as well as at Lys-216 (9 pmol) and Met-249 (4 pmol) at the N-termini of M1 and M2, respectively. The 3 H release profile was more complex than that seen for RM4, with the largest 3 H release occurring in cycles 10 (215 cpm) and 20 (140 cpm). Release in these cycles could result from [ 3 H]-Azicholesterol incorporation into Asp-436 and Ile-446 in the primary sequence, or from Cys-447 and Asp-557 in the secondary sequence beginning at Leu-438. Thus it is most likely that Asp-436 and Asp-457 at the N-and C-termini of the M4 segment are both labeled.
For the tryptic digest of γV8-14, HPLC fractions 37-40 were pooled and sequenced ( Figure 6C ). Fragments containing γM4 began at γVal-446 (18 pmol), 4 amino acids before the N-terminus of γM4, and at γGlu-429 (12 pmol), and there were also fragments containing γM3 (γThr-276 (28 pmol) and γM1 (γLys-218 (5 pmol), the N-terminus of γM1). The dominant 3 For the tryptic digest of δV8-11, sequence analysis ( Figure 6D ) of HPLC fractions 37-40 revealed the presence of overlapping fragments beginning at δAsn-437 (6 pmol) and δLeu-456 (7 pmol), the N-terminus of δM4, as well as fragments beginning at the N-termini of δM2 (δMet-257 (17 pmol)) and δM1 (δLys-224 (12 pmol)), and beginning at Thr-28 of the Na M1, M2, and M3, were further digested with V8 protease. When aliquots of each digest (∼10%) were fractionated on a Tricine SDS-PAGE gel and analyzed by fluorography (Figure 7 ), the following fragments were evident, based on the nomenclature of ref 12: RV8-8.5, V8-7 (just barely visible in this particular fluorograph), γV8-7.5, and δV8-7.5. These bands have previously been shown to contain the M3 segment of each nAChR subunit (12) . When the bulk of material from each V8 digest was resolved on a preparative scale Tricine SDS-PAGE gel, the bands corresponding to RV8-8.5, V8-7, γV8-7.5, and δV8-7.5 were excised (with the aid of prestained low-molecular weight range standards). When the material from each band was isolated and further purified by reversed-phase HPLC (Figure 8) (12) . Therefore, the M1 segment of each nAChR subunit was isolated from tryptic digests of RV8-20, V8-22, γV8-24, and δV8-20. The tryptic digests were resolved by Tricine SDS-PAGE, and in each case, the region of the gel between the 4-and 6-kDa molecular weight standards was excised. Also excised was the gel region containing an 8 kDa band that appeared prominently labeled in a fluo- rograph of an analytical Tricine SDS-PAGE gel containing a small aliquot of each digest (not shown). The material from each band was isolated and further purified by reversed-phase HPLC (Figure 9 ). For the RV8-20 tryptic digest, HPLC fractions 39-41 were pooled, and sequence analysis revealed the presence of a peptide beginning at RIle-210 (30 pmol), the amino-terminus of the RM1 segment as well as two secondary sequences (RAsp-180, 20 pmol; RMet-243, 10 pmol). On the basis of a molecular mass of 4-6 kDa, the RIle-210 peptide extends through the RM1 segment and likely terminates at RLys-242. For the other tryptic digests, HPLC fractions 37-40 were pooled, and in each case, sequence analysis revealed the presence of a primary peptide, although secondary sequences were present, which contain the M1 segment (the amino-terminus of each peptide was Lys-216 (211 pmol), γLys-218 (109 pmol), and δLys-224 (70 pmol)). The material from the 8 kDa band was also isolated and further purified by reversed-phase HPLC (data not shown). In each case, a single peak of 3 H-containing HPLC fractions was evident, and sequence analysis of the pooled fractions (39-42) revealed the presence of a primary sequence present in at least a 10-fold greater abundance than any secondary sequences: RIle-210 (132 pmol), Lys-216 (32 pmol), γLys-218 (19 pmol), and δLys-224 (74 pmol). On the basis of a molecular mass of 8 kDa, each peptide extends through both the M1 and M2 segments. The extent of [ 3 H]Azicholesterol incorporation into the M1 segments was too low to effectively allow for determination of individually labeled amino acids by radiosequencing. We note that, in the absence of radiosequencing, [ 3 H]Azicholesterol incorporation into the M1 segments (as well as M3 segments) can only be tentatively assigned based on peptide mapping results. However, the results do suggest the presence of [ 3 H]Azicholestrol incorporation into residues within the M1 segment of each nAChR subunit, a conclusion that is supported by previous photolabeling studies in which [ 125 I]-Azido-cholesterol labeling was mapped to the RM1 segment (18) .
DISCUSSION
The purpose of the work presented here was to probe the binding domain for membrane cholesterol in the nAChR using the photoactivatable sterol [3R-3 H]6-Azi-5R-cholestan-3 -ol ([ 3 H]Azicholesterol). [ 3 H]Azicholesterol inserts efficiently into nAChR-enriched membranes (>98%) and photoincorporates into nAChR subunits on an equal molar basis, and neither the pattern nor the extent of labeling is affected by the inclusion of the agonist carbamylcholine ( Figure 2 ). In addition, concentrations of nonradioactive Azicholesterol up to 100 µM had no effect on the highaffinity binding of either [ M3 segments, 26). Therefore, further mapping (i.e., identify labeled amino acids) with both [ (32) . On the other hand, the existence of nonannular versus annular lipid binding sites may be a temporal rather than a static phenomenon. At the lipid-protein interface, lipids have a lateral diffusion coefficient 50-100 times slower than that of the fluid lipid bilayer, and lipids that selectively interact with nAChR (e.g., cholesterol) spend on average a greater amount of time in proximity to the receptor (4) . While the present work suggests that cholesterol interacts with the entire lipid-protein interface, on a dynamic time-scale, cholesterol may interact preferentially with a subregion of the lipidprotein interface. Along these same lines, it is worth noting that [
3 H]Azicholesterol was added to Torpedo nAChRenriched membranes that already contain ∼35% cholesterol on a molar basis (6), which may limit contact with some cholesterol sites that are slowly exchanging.
The molecular interactions that underlie the effect of cholesterol on nAChR function are not understood. Cholesterol has no detectable effect on the overall secondary structure composition of the receptor protein (9) , and yet, nAChR state transitions are preserved in the presence of a single shell of lipids (∼45 lipids) surrounding the receptor protein (10) , and amino acid substitutions at residues that contact lipid have significant effects on channel gating (reviewed in ref 4). These results suggest that direct interactions between cholesterol and the nAChR lipidprotein interface exert subtle, yet critical, structural alterations that are necessary for receptor functionality. In a recent analysis of the effects of amino acid substitutions in the RM4 segment on channel gating, the authors concluded that the RM4-helix undergoes a rigid body motion during channel opening (11) . The details of this rigid body motion are unclear, particularly given that the surface of the RM4-helix that is exposed to lipid/sterol does not appear to change during channel activation (12, 33) . Any proposed model of how cholesterol interacts with the nAChR lipid-protein interface to facilitate gating-induced movements of the transmembrane segments must account for these seemingly conflicting results.
